Local Stage dependent necessity of Radiotherapy in Rhabdoid Tumors of the Kidney (RTK) - the GPOH experience.

[1]  B. Hoeben,et al.  Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group. , 2019, The Lancet. Oncology.

[2]  M. Gessler,et al.  The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol , 2018, Nature Reviews Urology.

[3]  S. Bens,et al.  The extraordinary challenge of treating patients with congenital rhabdoid tumors—a collaborative European effort , 2018, Pediatric blood & cancer.

[4]  C. Rübe,et al.  High‐dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival—The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience , 2018, Pediatric blood & cancer.

[5]  C. Rübe,et al.  Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol , 2017, Nature Reviews Urology.

[6]  A. Davidoff,et al.  Late toxicity and outcomes following radiation therapy for chest wall sarcomas in pediatric patients. , 2017, Practical radiation oncology.

[7]  P. Houghton,et al.  Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program , 2017, Pediatric blood & cancer.

[8]  A. Ferrari,et al.  Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005. , 2016, European journal of cancer.

[9]  P. Nathan,et al.  Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: A report from the Childhood Cancer Survivor Study , 2015, Cancer.

[10]  I. Leuschner,et al.  Malignant rhabdoid tumor of the kidney: significantly improved response to pre-operative treatment intensified with doxorubicin. , 2014, Cancer genetics.

[11]  Shengmei Zhou,et al.  High dose alkylator therapy for extracranial malignant rhabdoid tumors in children , 2014, Pediatric blood & cancer.

[12]  P. Modena,et al.  Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS) , 2014, Pediatric blood & cancer.

[13]  O. Witt,et al.  High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB) , 2014, Bone Marrow Transplantation.

[14]  K. Pritchard-Jones,et al.  Treatment of Wilms Tumour: The SIOP Approach , 2014 .

[15]  N Graf,et al.  Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. , 2013, European journal of cancer.

[16]  N. Breslow,et al.  Pulmonary disease after treatment for wilms tumor: A report from the national wilms tumor long‐term follow‐up study , 2013, Pediatric blood & cancer.

[17]  W. Dörr,et al.  Late bone and soft tissue sequelae of childhood radiotherapy , 2013, Strahlentherapie und Onkologie.

[18]  Norbert Graf,et al.  Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01. , 2012, European journal of cancer.

[19]  K. Pritchard-Jones,et al.  Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study group , 2011, Pediatric blood & cancer.

[20]  N. Breslow,et al.  Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C. Rodríguez-Galindo,et al.  Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors , 2010, Pediatric blood & cancer.

[22]  I. Leuschner,et al.  Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. , 2008, Oncology reports.

[23]  N. Breslow,et al.  Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Stöckle,et al.  Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  P. Voûte,et al.  Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  Dieter Harms,et al.  Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. , 2002, Medical and pediatric oncology.

[27]  N. Breslow,et al.  Stature loss following treatment for Wilms tumor. , 2001, Medical and pediatric oncology.

[28]  S. Donaldson,et al.  Radiation induced height impairment in pediatric Hodgkin's disease. , 1994, International journal of radiation oncology, biology, physics.